(Q33563718)

28 July 2017

Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D (English)

1 reference

28 July 2017

0 references

Ann B Nattinger

1

1 reference

28 July 2017

Erica M Wozniak

2

1 reference

28 July 2017

Emily L McGinley

3

1 reference

28 July 2017

Jianing Li

4

1 reference

28 July 2017

Purushottam Laud

5

1 reference

28 July 2017

Liliana E Pezzin

6

1 reference

28 July 2017

27 December 2016

1 reference

28 July 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Medical Care

1 reference

28 July 2017

55

1 reference

28 July 2017

5

1 reference

28 July 2017

463-469

1 reference

The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Choice Inconsistencies Among the Elderly: Evidence from Plan Choice in the Medicare Part D Program

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Socioeconomic status and survival after an invasive breast cancer diagnosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

The economic consequences of breast cancer adjuvant hormonal treatments

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

An algorithm for the use of Medicare claims data to identify women with incident breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Providing prescription drug coverage to the elderly: America's experiment with Medicare Part D.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Race, socioeconomic status, and breast cancer treatment and survival

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Trends in Area-Socioeconomic and Race-Ethnic Disparities in Breast Cancer Incidence, Stage at Diagnosis, Screening, Mortality, and Survival among Women Ages 50 Years and Over (1987-2005)

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5391268

Who failed to enroll in Medicare Part D, and why? Early results

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28030476

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

What drives diffusion of new cancer therapies?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28030476

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/MLR.0000000000000685

1 reference

28 July 2017

1 reference

28 July 2017

1 reference